# US 2026/0216041 A1 · In-silico-designed botulinum toxin mimetic peptide for inhibiting release of neurotransmitters including acetylcholine, and use thereof in wrinkle reduction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0216041 A1
- Document ID: US20260216041A1
- Status: Published application
- Kind: A1
- Application number: 19/141,390
- Filed: 2023-12-21
- Published: 2026-07-30
- Earliest claimed: 2022-12-21
- Assignees: Medytox Inc.
- Applicants: Medytox Inc.
- Inventors: Su Hyeok KIM; Hyo Jeong CHOI; Min Hee SHIN; Dong Kyu LEE
- Web page: https://patentgrep.com/patent/US20260216041A1

## CPC

- A61K 8/66: Enzymes
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61P 17/00: Drugs for dermatological disorders
- A61Q 19/02: for chemically bleaching or whitening the skin
- A61Q 19/08: Anti-ageing preparations
- C07K 14/47: from mammals
- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- C12N 9/52: derived from bacteria {or Archaea}
- C12Y 304/24069: Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Provided are a peptide that inhibits the secretion of neurotransmitters from cells, and uses thereof.

## Claims

### Claim 1

A peptide that inhibits secretion of neurotransmitters from neurons, wherein the peptide has the amino acid sequence of SEQ ID NO: 1.

### Claim 2 (depends on 1)

The peptide of claim 1, not linked to a cell permeable peptide.

### Claim 3 (depends on 1)

The peptide of claim 1, wherein an N-terminus of the peptide is bonded to any one protecting group selected from the group consisting of an acetyl group, a fluorenylmethoxycarbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, a butoxycarbonyl group, an allyloxycarbonyl group, and polyethylene glycol (PEG).

### Claim 4 (depends on 1)

The peptide of claim 1, wherein a C-terminus of the peptide is bonded to any one protecting group selected from the group consisting of an amino group (—NH2), a tertiary alkyl group, and a hydrozino group (—NHNH2).

### Claim 5 (depends on 1)

The peptide of claim 1, wherein the neurotransmitters are dopamine, acetylcholine, epinephrine, norepinephrine, serotonin, histamine, glutamate, glycine, gamma-aminobutyric acid or a combination thereof.

### Claim 6 (depends on 1)

A composition, comprising the peptide according to claim 1 as an active ingredient.

### Claim 7

(canceled)

### Claim 8 (depends on 6)

The composition of claim 6, further comprising one or more selected from the group consisting of a diluent, an excipient, a carrier, and an adjuvant.

### Claim 9 (depends on 1)

A method of skin whitening or wrinkle improvement, comprising administering to a subject the peptide according to claim 1 in an amount effective for skin whitening or wrinkle improvement.

### Claim 10 (depends on 9)

The method of claim 9, wherein the method is for makeup application.
